Drawing for IO

USPTO serial 79358304

IO

Reviewed by CopyMark Law Group

Reg. 7333993Status 700Registered
Filing date
Status date
Registration date
Mar 26, 2024
Examiner
CLYBURN, CARLA DIONNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological preparations used in industry and scienceACTIVE
005Pharmaceutical and veterinary pharmaceutical preparations and substances for treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; diagnostic preparations for medical purposes in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; biopharmaceutical, biological and chemical preparations and substances for medical use in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; pharmaceutical and veterinary pharmaceutical preparations and substances for the treatment of cancer, regulation of the immune system, treatment of diseases of the immune system and cell therapyACTIVE
010Surgical, medical and veterinary apparatus and instruments; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this classACTIVE
042Scientific and technological services, namely, research and design in the fields of oncology, immunology and cell therapy; scientific and technological analysis services in the field of research, development and diagnostics; industrial analysis of blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; industrial research services in the field of oncology, immunology and cell therapy; scientific and medical research in the field of cancer or diseases of the immune system; research and development in the field of oncology, immunology and cell therapyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB
Oct 16, 2024FIMPFINAL DISPOSITION PROCESSED
Jun 27, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 26, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 26, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 8, 2024GPNXNOTIFICATION PROCESSED BY IB
Dec 20, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 20, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 20, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2023LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW
Nov 4, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 14, 2023LIMGLIMITATION OF GOODS RECEIVED FROM IB
Jun 26, 2023RFNPREFUSAL PROCESSED BY IB
Jun 6, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 5, 2023RFRRREFUSAL PROCESSED BY MPU
Apr 7, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2023DOCKASSIGNED TO EXAMINER
Dec 31, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Dec 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance